Diploma (LON:DPLM) Shares Up 15.1% – Still a Buy?

Diploma PLC (LON:DPLM) shot up 15.1% on Wednesday . The stock traded as high as GBX 5,025 ($67.30) and last traded at GBX 4,860 ($65.09). 975,747 shares were traded during trading, an increase of 115% from the average session volume of 453,933 shares. The stock had previously closed at GBX 4,222 ($56.54).

Diploma Price Performance

The business’s 50 day moving average price is GBX 3,949.28 and its 200-day moving average price is GBX 4,253.28. The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80. The company has a market cap of £6.48 billion, a P/E ratio of 55.86, a PEG ratio of 2.82 and a beta of 0.75.

Diploma (LON:DPLM) last announced its earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.07) earnings per share for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. On average, analysts anticipate that Diploma PLC will post 163.7995512 earnings per share for the current fiscal year.

Insider Activity

In other Diploma news, insider David S. Lowden purchased 750 shares of the company’s stock in a transaction that occurred on Friday, March 21st. The stock was acquired at an average cost of GBX 3,928 ($52.60) per share, with a total value of £29,460 ($39,453.60). Also, insider Ian El-Mokadem acquired 500 shares of the business’s stock in a transaction that occurred on Monday, March 24th. The stock was acquired at an average price of GBX 3,948 ($52.87) per share, for a total transaction of £19,740 ($26,436.32). 0.52% of the stock is currently owned by insiders.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.